Company & Sponsor Intelligence

Imperial College London

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting2

Completed0

Countries2

Therapeutic footprint

alzheimersother_neurology

Indexed studies

NCT02874820I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD
alzheimers · United KingdomEARLY_PHASE1

NCT05395195Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
other_neurology · BangladeshPHASE3

NCT07401849Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care
alzheimers · NOT_YET_RECRUITING

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →